Found 6 matching trials
Evaluate Efficacy of Devimistat in Combination With mFFX in 2nd Line Patients With Metastatic Pancreatic Cancer
PHASE2Open label, randomized phase II study to evaluate efficacy and safety of CP...
Location
Hirschfeld Oncology
CPI-613 in Combination With Modified FOLFIRINOX in Patients With Locally Advanced Pancreatic Cancer
PHASE2This study is a single arm, phase II trial, of 45 patients with locally adv...
Location
Multiple Locations
Study Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the Pancreas
PHASE3A prospective, multicenter, open label, randomized phase III study to evalu...
Location
Banner MD Anderson Cancer Center
CPI-613 and Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer
PHASE1This phase I trial studies the side effects and best dose of CPI-613 when g...
Location
Comprehensive Cancer Center of Wake Forest University
CPI-613 in Combination With Modified FOLFIRINOX in Locally Advanced Pancreatic Cancer
PHASE1The purpose of this study is to treat participants with the combination of ...
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
CPI-613 (Devimistat) in Combination With Modified FOLFIRINOX Plus Bevacizumab in Patients With Metastatic Colorectal Cancer
PHASE1Pre-clinical in vitro and in vivo data as well as early phase 1 clinical tr...
Location
Multiple Locations